New Laboratory Facilities for Leading DNA Sequencing at NOVI Science Park
To support DNASense's expanding activities, NOVI is currently constructing new, advanced laboratory facilities. These facilities are custom-designed for state-of-the-art DNA/RNA extraction and sequencing and will play a central role in the company’s future growth. Located in NOVI 3-4, the laboratories are expected to be completed by January 2025 and will serve as the hub for processing all Cmbio’s DNA/RNA samples from the EU and surrounding regions.
DNASense as a Subsidiary of Cmbio
In March 2024, DNASense was acquired by Cmbio, marking a significant milestone in the company's growth journey. As a subsidiary of Cmbio, one of the world’s leading companies in microbiome analysis, DNASense’s position is further strengthened, with significantly enhanced access to international markets. DNASense will manage all DNA/RNA sequencing samples for Cmbio from the EU and surrounding regions, with operations centralized in the new DNASense-NOVI laboratory facilities.
PHOTO: Director Mads T. Søndergaard and Principal Research Scientist Mie Bech Lukassen have been partners in DNASense, which has been based in NOVI Science Park since its early days as a spin-out from Aalborg University.